Revolution Medicines (RVMD) Intangibles (2019 - 2026)

Revolution Medicines' Intangibles history runs 8 years deep, the most recent figure standing at $55.8 million for Q1 2026.

• In Q1 2026, Intangibles fell 1.07% year-over-year to $55.8 million; the TTM figure through Mar 2026 stood at $55.8 million (down 1.07% YoY), while the FY2025 annual figure was $63.3 million, up 11.66% from the prior year.
• Intangibles was $55.8 million for Q1 2026 at Revolution Medicines, down from $63.3 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $63.3 million in Q2 2022 to a low of $69000.0 in Q3 2025.
• Historically, Intangibles has averaged $55.4 million across 5 years, with a median of $56.4 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Intangibles rose 13.41% in 2022, then sank 99.89% in 2025.
• A 5-year view of Intangibles shows it stood at $55.8 million in 2022, then gained by 13.41% to $63.3 million in 2023, then dropped by 10.45% to $56.7 million in 2024, then increased by 11.66% to $63.3 million in 2025, then fell by 11.82% to $55.8 million in 2026.
• The last three Intangibles figures came in at $55.8 million (Q1 2026), $63.3 million (Q4 2025), and $69000.0 (Q3 2025), per Business Quant data.